After viewing this slide library, dermatologists and other physicians should be able to:

• Differentiate superficial fungal infections from other cutaneous infections.
• Outline the clinical presentation, epidemiology, risk factors of, and organisms responsible for superficial fungal infections, such as intertrigo and the tineas.
• Identify factors relevant to choice of antifungal agent in treatment of specific infections, such a range of efficacy, ease of use, cost, anti-inflammatory/antipruritic properties and the role of vehicle in efficacy.
• Describe differences between the use of topical and systemic therapies for fungal infections.

Bonnie E. Elewski, MD
Professor of Dermatology
Department of Dermatology
University of Alabama at Birmingham
Birmingham, Alabama

James Q. Del Rosso, DO, FAOCD
Clinical Associate Professor (Dermatology)
University of Nevada School of Medicine
Touro University College of Osteopathic Medicine
Dermatology Residency Director
Valley Hospital Medical Center
Las Vegas, Nevada

Zoe Diana Draelos, MD
Dermatology Consulting Services
High Point, North Carolina

Joseph L. Jorizzo, MD
Professor, Founding and Former Chair; Department of Dermatology
Wake Forest University School of Medicine
Winston-Samel, North Carolina

Warren S. Joseph, DPM
VAMC-Coatesville, PA
Editor, Journal of the APMA

Phoebe Rich, MD
Clinical Associate Professor
Department of Dermatology
Oregon Health & Science University
Portland, Oregon

In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, the faculty make the following financial disclosures:

Boni E. Elewski, MD - Consultant: OrthoNeutrogena

James Del Rosso, DO, FAOCD - Grants/research support: OrthoNeutrogena, Medicis; Consultant: OrthoNeutrogene, Novartis, Medicis; Honorarium: OrthoNeutrogena, Novartis, Medicis

Zoe Draelos, MD - Nothing to disclose

Joseph L. Jorizzo, MD - Honorarium: OrthoNeutrogena, Johnson & Johnson

Warren S. Joseph, DPM - Consultant: Stiefel; Honorarium: Stiefel, Sanofi-Aventis

Phoebe Rich, MD - Consultant: OrthoNeutrogena; Honorarium: OrthoNeutrogena

Because of the nature of preliminary studies, some products mentioned are unlabeled and investigational. Dosages, indications, and methods of use of drugs mentioned in this publication may reflect the experience of the authors, clinical literature, or other resources. Therefore, please see the full prescribing information before using any licensed product mentioned.

The University of Alabama School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Alabama School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The boards of nursing in many states, including Alabama, recognize Category 1 continuing medical education courses as acceptable activities for the renewal of license to practice nursing.

To view the slides, click on the links below.

To receive CME credit for viewing the presentations, please read and reflect on the information and complete the self assessment test from the link at the bottom of the page. Your CME certificate will then be available to you online.

References